ImmunoGen (Nasdaq:IMGN) develops antibody-based anticancer therapeutics.
Recent Mentions on Fool.com
- 3 Potentially Game-Changing Investigational Breast Cancer Drugs That May Soon Be Available
- Why Geron, Restoration Hardware, and ImmunoGen Are Today's 3 Best Stocks
- Rising R&D Expenses Drive ImmunoGen's Q3 Loss Significantly Higher
- The Fool Looks Ahead
- Why Zogenix, ImmunoGen, and voxeljet Are Today's 3 Best Stocks